AKT1 and glioblastoma: Here, we validated that ADAM8 activates HB-EGF/EGFR signaling pathways in GBM cells as a consequence of TMZ treatment, and ADAM8 knockdown markedly reduced the phosphorylation of EGFR and subsequently the activation of EGFR downstream signals (AKT and ERK signaling).